Day: November 27, 2023

VANCOUVER, British Columbia, Nov. 27, 2023 (GLOBE NEWSWIRE) — NINE MILE METALS LTD. (CSE: NINE, OTCQB: VMSXF, FSE: KQ9) (the “Company” or “Nine Mile”), discloses that it will update the proposed unsecured loan financing for proceeds of up to $500,000 that it announced in the Company’s news release on November 21, 2023, to an unsecured convertible loan financing (the “Convertible Loan”). The Convertible Loan financing will be for proceeds of up to $500,000. The Convertible Loans will have a term of 12 months from the closing (the “Maturity Date”) and bear interest at 15 per cent per annum, calculated and payable on the Maturity Date. Convertible Loan proceeds will be used for advancing the bulk sample program on the Nine Mile Brook project and general working capital. No bonus shares will be offered in connection with the Convertible...

– Approval based on positive data from Phase 3 DeFi trial, in which OGSIVEO significantly improved progression-free survival and objective response rate, with rapid and sustained improvements in pain, physical functioning and overall quality of life – – SpringWorks to host conference call tomorrow at 8:00 a.m. ET –A Media Snippet accompanying this announcement is available by clicking on this link. STAMFORD, Conn., Nov. 27, 2023 (GLOBE NEWSWIRE) — SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, announced today that the U.S. Food and Drug Administration (FDA) has approved OGSIVEO™ (nirogacestat), an oral gamma secretase inhibitor, for the treatment of adult patients with progressing desmoid tumors who require systemic treatment.1 The...

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Nov. 27, 2023 (GLOBE NEWSWIRE) — NorthWest Copper Corp. (the “Company” or “NorthWest”) (TSX-V: NWST) announces it is undertaking a rights offering to raise gross proceeds of up to $3,340,936 (the “Rights Offering”) and private placements to bring the total amount raised by the Company to no more than $4,000,000 (“Concurrent Private Placement”). Rights Offering Pursuant to the Rights Offering, the Company will be offering 31,818,435 rights (the “Rights”) to holders (the “Shareholders) of common shares in the capital of NorthWest (the “NorthWest Shares”) at the close of business on the record date of December 5, 2023 (the “Record Date”) on the basis of one (1) Right for each six (6) NorthWest Shares held....

BROOKFIELD, NEWS, Nov. 27, 2023 (GLOBE NEWSWIRE) — Brookfield Corporation (“Brookfield”) (NYSE: BN, TSX: BN) today announced the pricing of a public offering of $700 million principal amount of senior notes due 2034 (the “notes”), which will bear interest at a rate of 6.350% per annum. The net proceeds from the sale of the notes will be used to refinance existing indebtedness, including upcoming 2024 maturities, and will leave only modest maturities through to the end of 2025.  The notes will be issued by Brookfield Finance Inc., an indirect 100% owned subsidiary of Brookfield, and will be fully and unconditionally guaranteed by Brookfield. The offering is expected to close on or about December 4, 2023, subject to the satisfaction of customary closing conditions. The notes are being offered under Brookfield and the issuer’s existing...

BRYAN, Texas and SAN DIEGO, Nov. 27, 2023 (GLOBE NEWSWIRE) — iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”) today announced that its Board of Directors has approved a 20-to-1 reverse split of the Company’s common stock, par value $0.001 per share (the “Common Stock”) effective at 12:01 a.m. ET on November 29, 2023 (the “Effective Date”). The Common Stock is expected to begin trading on a split-adjusted basis when the market opens on November 29, 2023, with the new CUSIP number 451033708.    The reverse stock split was authorized by iBio’s stockholders at the Company’s 2023 Annual Meeting, held earlier today, with a ratio ranging from 1-for-5 to 1-for-20 (the “Range”), with the ration within such Range to be determined at the discretion of the Company’s Board of Directors. As a result of the reverse stock split, every 20 shares...

CHANDLER, Ariz., Nov. 27, 2023 (GLOBE NEWSWIRE) — (NASDAQ:MCHP) – Microchip Technology Incorporated, a leading provider of smart, connected, and secure embedded control solutions, today announced that the Company will present at the UBS Technology Conference on Tuesday, November 28 at 9:35 a.m. (Mountain Time). Presenting for the Company will be Mr. Ganesh Moorthy, President and CEO. A live webcast of the presentation will be made available by UBS, and can be accessed on the Microchip website at www.microchip.com. Any forward looking statements made during the presentation are qualified in their entirety by the discussion of risks set forth in the Company’s Securities and Exchange Commission filings. Copies of SEC filings can be obtained for free at the SEC’s website (www.sec.gov) or from commercial document retrieval...

Sale Expected to Result in Immediate and Significant Reduction in Operating Costs and Cash Requirements BUFFALO, N.Y., Nov. 27, 2023 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII) (the “Company” or “22nd Century”), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness, today announced it has reached an agreement to sell substantially all of its GVB Biopharma (“GVB”) hemp/cannabis operations to Specialty Acquisition Corporation, a Nevada corporation (the “Buyer”), an entity affiliated with current GVB employees. The transaction is subject to certain approvals and Buyer obtaining financing. Terms of the transaction include a cash payment to the Company of $1 million at closing of the sale (the “Closing”) and a 12% secured promissory note for $1.25 million issued...